ProCE Banner Activity

My Takeaways From Data on Long-Acting ART Presented at CROI 2021

Conference Coverage
Clinical Thought
Data on long-acting ART continued to dominate the presentations at CROI 2021. Here are my thoughts on the practicalities of potentially integrating these new drugs into my practice in Canada.

Released: April 01, 2021

Expiration: March 31, 2022

Share

Faculty

Darrell H S Tan

Darrell H S Tan, MD, FRCPC, PhD

Clinician-Scientist
Division of Infectious Diseases
St Michael's Hospital
Toronto, Ontario, Canada

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Faculty Disclosure

Primary Author

Darrell H S Tan, MD, FRCPC, PhD

Clinician-Scientist
Division of Infectious Diseases
St Michael's Hospital
Toronto, Ontario, Canada

Darrell Tan, MD, FRCPC, PhD, has disclosed that he has received funds for research support from AbbVie, GlaxoSmithKline, and Gilead Sciences.